biperiden

biperiden
Clinical data
Trade names	Akineton
AHFS/Drugs.com	Monograph
MedlinePlus	a699058
License data	US DailyMed: Biperiden;
Pregnancy; category	AU: B2;
Routes of; administration	By mouth, intramuscular injection (IM), intravenous therapy (IV)
ATC code	N04AA02 (WHO) ;
Legal status
Legal status	BR: Class C1 (Other controlled substances); US: ℞-only;
Pharmacokinetic data
Bioavailability	33 ± 5% (by mouth)
Protein binding	60%
Metabolism	Liver hydroxylation
Elimination half-life	18 to 24 hours
Excretion	Kidney
Identifiers
	IUPAC name (1RS,2SR,4RS)-1-(bicyclo[2.2.1]hept-5-en-2-yl)-1-phenyl-3-(piperidin- 1-yl)propan-1-ol;
CAS Number	514-65-8 ;
PubChem CID	2381;
IUPHAR/BPS	7128;
DrugBank	DB00810 ;
ChemSpider	2289 ;
UNII	0FRP6G56LD;
KEGG	D00779 ;
ChEBI	CHEBI:3112 ;
ChEMBL	ChEMBL1101 ;
Chemical and physical data
Formula	C21H29NO
Molar mass	311.469 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES OC(c1ccccc1)(CCN2CCCCC2)C4C3\C=C/C(C3)C4;
	InChI InChI=1S/C21H29NO/c23-21(19-7-3-1-4-8-19,11-14-22-12-5-2-6-13-22)20-16-17-9-10-18(20)15-17/h1,3-4,7-10,17-18,20,23H,2,5-6,11-16H2 ; Key:YSXKPIUOCJLQIE-UHFFFAOYSA-N ;
	(verify)